 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 December 1998 | Volume 129 Issue 11 Part 1 | Pages 886-890
Purpose: To determine the strength of clinical evidence for individual drugs as a cause of thrombocytopenia.
Data Sources: All English-language reports on drug-induced thrombocytopenia.
Study Selection: Articles describing thrombocytopenia caused by heparin were excluded from review. Of the 581 articles reviewed, 20 were excluded because they contained no patient case reports. The remaining 561 articles reported on 774 patients.
Data Extraction: Two of the authors used a priori criteria to independently review each patient case report. Two hundred fifty-nine patient case reports were excluded from further review because of lack of evaluable data, platelet count of 100 000 cells/µL or more, use of cytotoxic or nontherapeutic agents, occurrence of drug-induced systemic disease, or occurrence of disease in children. For the remaining 515 patient case reports, a level of evidence for the drug as the cause of thrombocytopenia was assigned. Data on bleeding complications and clinical course were recorded.
Data Synthesis: The evidence supported a definite or probable causal role for the drug in 247 patient case reports (48%). Among the 98 drugs described in these reports, quinidine was mentioned in 38 case reports, gold in 11, and trimethoprim-sulfamethoxazole in 10. Of the 247 patients described in the case reports, 23 (9%) had major bleeding and 2 (0.8%) died of bleeding.
Conclusions: Many reports of drug-induced thrombocytopenia do not provide evidence supporting a definite or probable causal relation between the disease and the drug. Future patient case reports should incorporate standard criteria to clearly establish the etiologic role of the drug.
Author and Article Information
From University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
REVIEW
Drug-Induced Thrombocytopenia
A Systematic Review of Published Case Reports
Note: A complete list of drugs implicated in patient case reports can also be found in the electronic version of this paper at http://www.acponline.org.
Requests for Reprints: James N. George, MD, Hematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Box 26901, Oklahoma City, OK 73190.
Current Author Addresses: Dr. George: Hematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Box 26901, Oklahoma City, OK 73190. Mr. Raskob, Drs. Shah and Rizvi, and Mr. Osborne: Department of Medicine, University of Oklahoma Health Sciences Center, Box 26901, Oklahoma City, OK 73190.
Dr. Hamilton: Cancer Treatment Center, 230 North Midwest Boulevard, Suite 200, Midwest City, OK 73110.
Dr. Vondracek: College of Pharmacy, 1110 North Stonewall, Oklahoma City, OK 73104.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  A. Philip, S. Ramchandani, K. Dorrance, and C. Dorrance Sildenafil-Induced Thrombocytopenia Ann Intern Med, September 16, 2008; 149(6): 437 - 439. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pattis and C. J Wiedermann Ezetimibe-Associated Immune Thrombocytopenia Ann. Pharmacother., March 1, 2008; 42(3): 430 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V.K. Naina, S. Harris, A. C. Matzdorff, R. Cathomas, A. Goldhirsch, R. von Moos, R. H. Aster, and D. W. Bougie Drug-Induced Immune Thrombocytopenia N. Engl. J. Med., November 1, 2007; 357(18): 1869 - 1871. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Aster and D. W. Bougie Drug-Induced Immune Thrombocytopenia N. Engl. J. Med., August 9, 2007; 357(6): 580 - 587. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Salar, X. Bessa, E. Muniz, D. Monfort, C. Besses, and M. Andreu Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease Gut, August 1, 2007; 56(8): 1169 - 1170. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Biner, O. Devecioglu, and M. Demir Pitfalls in the Diagnosis of Immune Thrombocytopenic Purpura in Children: 4 Case Reports Clinical and Applied Thrombosis/Hemostasis, July 1, 2007; 13(3): 329 - 333. [Abstract] [PDF]
|
|
|
|
 |
|
 L Cantarini, I Tinazzi, D Biasi, A Fioravanti, and M Galeazzi Sulfasalazine-induced immune thrombocytopenia Postgrad. Med. J., June 1, 2007; 83(980): e1 - e1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. George Evaluation and Management of Patients With Thrombotic Thrombocytopenic Purpura J Intensive Care Med, March 1, 2007; 22(2): 82 - 91. [Abstract] [PDF]
|
|
|
|
|
|
A. Von Drygalski, B. R. Curtis, D. W. Bougie, J. G. McFarland, S. Ahl, I. Limbu, K. R. Baker, and R. H. Aster Vancomycin-Induced Immune Thrombocytopenia N. Engl. J. Med., March 1, 2007; 356(9): 904 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Gerber, S. A. Grossman, M. Zeltzman, M. A. Parisi, and L. Kleinberg The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas Neuro-oncol, January 1, 2007; 9(1): 47 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Crowther and T. C. Abshire Hemostasis and thrombosis ASH Self-Assessment Program, January 1, 2007; 2007(1): 361 - 407. [Full Text] [PDF]
|
|
|
|
 |
|
 W S A Smellie, J Forth, D Bareford, P Twomey, M J Galloway, E C M Logan, S R S Smart, T M Reynolds, and C Waine Best practice in primary care pathology: review 3. J. Clin. Pathol., August 1, 2006; 59(8): 781 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Bougie, P. R. Wilker, and R. H. Aster Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies Blood, August 1, 2006; 108(3): 922 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lasne, B. Jude, and S. Susen From normal to pathological hemostasis: [De l'hemostase normale a l'hemostase pathologique]. Can J Anesth, June 1, 2006; 53(6_suppl): S2 - S11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. de Maistre, Y. Gruel, and D. Lasne Diagnosis and management of heparin-induced thrombocytopenia: [Le diagnostic et le traitement de la thrombopenie induite par l'heparine]. Can J Anesth, June 1, 2006; 53(6_suppl): S123 - S134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D Watson, J. E Stark, and K. S Vesta Pantoprazole-Induced Thrombocytopenia Ann. Pharmacother., April 1, 2006; 40(4): 758 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and P. Kwon Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis Ann Intern Med, November 15, 2005; 143(10): 761 - 763. [Full Text] [PDF]
|
|
|
|
|
|
X. Li, L. Hunt, and S. K. Vesely Drug-Induced Thrombocytopenia: An Updated Systematic Review Ann Intern Med, March 15, 2005; 142(6): 474 - 475. [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Davis Hematology in palliative medicine American Journal of Hospice and Palliative Medicine, November 1, 2004; 21(6): 445 - 454. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Kodjikian, B. Durand, C. Burillon, F. Rouberol, J.-D. Grange, and P. Renaudier Acetazolamide-Induced Thrombocytopenia Arch Ophthalmol, October 1, 2004; 122(10): 1543 - 1544. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Reddy, M. A. Shuman, and R. H. Aster Quinine/Quinidine-Induced Thrombocytopenia: A Great Imitator Arch Intern Med, January 26, 2004; 164(2): 218 - 220. [Full Text] [PDF]
|
|
|
|
|
|
S. K. Vesely, J. J. Perdue, M. A. Rizvi, D. R. Terrell, and J. N. George Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy: A Systematic Review Ann Intern Med, January 20, 2004; 140(2): 112 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. George and S. K. Vesely Immune Thrombocytopenic Purpura -- Let the Treatment Fit the Patient N. Engl. J. Med., August 28, 2003; 349(9): 903 - 905. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kentos, V. Robin, M. Lambermont, M. Jurdan, M. Pignarelli, and W. Feremans Probable rofecoxib-induced thrombocytopenia Rheumatology, May 1, 2003; 42(5): 699 - 700. [Full Text] [PDF]
|
|
|
|
|
|
A. B. Hibbard, P. J. Medina, and S. K. Vesely Reports of Drug-Induced Thrombocytopenia Ann Intern Med, February 4, 2003; 138(3): 239 - 239. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Peterson, C. E. Nyree, P. J. Newman, and R. H. Aster A site involving the "hybrid" and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia Blood, February 1, 2003; 101(3): 937 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. DeLoughery Thrombocytopenia in Critical Care Patients J Intensive Care Med, November 1, 2002; 17(6): 267 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Mureebe and D. Silver Heparin-Induced Thrombocytopenia: Pathophysiology and Management Vascular and Endovascular Surgery, May 1, 2002; 36(3): 163 - 170. [Abstract] [PDF]
|
|
|
|
|
|
H. L. Messmore JR Heparin-Induced Thrombocytopenia: Historical Review Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(1_suppl): S2 - S6. [Abstract] [PDF]
|
|
Article
